insights_auto
Sebab MVIR menurun 7.12%?
Terokai Dengan Lebih Terperincichevron_right
MVIR:STO
Medivir AB
SEK 1.04
arrow_downward
-7.12%(-0.080) 1H
20 Nov, 5:29:48 PTG GMT+1 · SEK
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk MVIR...
Buka
SEK 1.12
Tinggi
SEK 1.13
Rendah
SEK 1.03
Permodalan Pasaran
653.97J
Purata volum
2.05J
Volum
2.43J
tgi 52 mgu
SEK 2.88
rdh 52 mgu
SEK 0.34
EPS
-SEK 0.27
Syer tertunggak
624.18J
Bilangan pekerja
7
Buka
SEK 1.12
Tinggi
SEK 1.13
Rendah
SEK 1.03
Permodalan Pasaran
653.97J
Purata volum
2.05J
Volum
2.43J
tgi 52 mgu
SEK 2.88
rdh 52 mgu
SEK 0.34
EPS
-SEK 0.27
Syer tertunggak
624.18J
Bilangan pekerja
7
Cerita berita
Daripada sumber web dan rakan kongsi berita
WHEC.com
·
1 jam lalu
US stocks tumble, and the S&P 500 drops as the sell-off for AI stocks accelerates
Traders Union
·
2 jam lalu
S&P 500 P/E multiples range from 15.7x to 19.6x depending on EPS assumptions, Michael Kantro notes
ChartMill
·
1 jam lalu
S&P 500 Session Movers: Fair Isaac Leads Gainers, Coherent Leads Decliners
Profil
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
Perihal Medivir AB